Stephen Ross

University of California, San Francisco — United States

Psychology · Social Sciences

44h-index9.6kcitations166works7.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psychedelics and Drug Studies(37), Sports, Gender, and Society(36), Chemical synthesis and alkaloids(26), Sport and Mega-Event Impacts(23), Plant Physiology and Cultivation Studies(20)

Publications165 total

Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion
2025Open Access
Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders
Psychedelics.·2025Open Access
Cost-Effectiveness of α<sub>2</sub> Agonists for Intravenous Sedation in Patients With Critical Illness
JAMA Network Open·2025· 1 citedOpen Access
Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions
Psychedelic Medicine·2025· 10 cited
Exploring serotonergic psychedelics as a treatment for personality disorders
Neuropharmacology·2025· 3 cited
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
Psychedelic Medicine·2025· 4 citedOpen Access
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial
American Journal of Psychiatry·2025· 17 cited
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer
Nature Mental Health·2024· 8 cited
PR012/#955  Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial
2024
Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directors
International Review of Psychiatry·2024· 2 cited
Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application—a review
Annals of Palliative Medicine·2024· 7 citedOpen Access
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
European journal of psychotraumatology·2024· 28 citedOpen Access
Older adults in psychedelic-assisted therapy trials: A systematic review
Journal of Psychopharmacology·2024· 16 cited
Single-Dose Psilocybin Treatment for Major Depressive Disorder
JAMA·2023· 427 citedOpen Access
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Scientific Reports·2023· 28 citedOpen Access
What Is in a Name? The Many Meanings of “Psychedelic”
Psychedelic Medicine·2023· 12 citedOpen Access
Fear of cancer recurrence inventory scores and their correlation with quality of life and stress levels in breast cancer survivors.
Journal of Clinical Oncology·2023· 3 cited
Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis
Journal of Palliative Medicine·2023· 5 cited
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
Neuropharmacology·2023· 28 citedOpen Access
Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress
Psychedelic Medicine·2023· 2 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Rui Biscaia(8), Anthony P. Bossis(6), Jeffrey Guss(6), Gabrielle Agin-Liebes(6), Sarah E. Mennenga(6), Abel Correia(6), António Rosado(5), Tara C. Malone(4), Alexander Belser(4), John Rotrosen(4), Michael P. Bogenschutz(4), João Marôco(4), Hyejin Bang(4), Lindsey T. Owens(3), Samantha K. Podrebarac(3), Jeffrey James(3), Eric D. Peselow(3), Yongjae Kim(3), Masayuki Yoshida(3), Patrick Walsh(3)